Alemtuzumab

Study	Exclusion reasons	Rmk	Reference
Rog, 2017	case report or case series		Rog 7th Joint ECTRIMS and ACTRIMS congress, Paris, France, 25-28 October 2017
Willis, 2016	case report or case series	'Thirteen pregnancies were recorded in twelve women (18%). Two pregnancies resulted inmiscarriage and one was terminated. The child of one patient who developed thyroid AID following treat- ment experienced transient neonatal hyperthyroidism.'	Willis Mult. Scler. 2016; 22:1215-23 10.1177/1352458515614092
Tuohy, 2015	not in pregnancy	'A total of 15 babies were born to 12 women treated with alemtuzumab during the course of the follow-up period after a median interval from most recent treatment of 26 months (range 13–86months). All deliveries and births were uncomplicated.'	Tuohy J. Neurol. Neurosurg. Psychiatry 2015; 86:208-15 10.1136/jnnp-2014-307721